Predictors of Cessation Pharmacotherapy Use Among Black and Non-Hispanic White Smokers
- 4 April 2011
- journal article
- Published by Oxford University Press (OUP) in Nicotine & Tobacco Research
- Vol. 13 (8) , 646-652
Abstract
Use of pharmacotherapy for smoking cessation improves quit rates, but these treatments are underutilized, particularly among Black smokers. Attitudes toward pharmacotherapy may differ between racial/ethnic minorities and Caucasian smokers. It was hypothesized that Black and non-Hispanic White smokers would differ in their attitudes toward pharmacotherapy and that the association between attitudes toward and actual use of pharmacotherapy would differ by race. The study consisted of a single, cross-sectional telephone-based survey of current smokers (N = 697), which examined the relationship between race, attitudes toward pharmacotherapy, and pharmacotherapy usage in a representative bi-racial sample (39% Black). Black smokers were significantly less likely to report ever use of pharmacotherapy (23%) than Caucasians (39%; odds ratio [OR] = 0.46; 95% CI: 0.33-0.66). Compared with Caucasians, Blacks had significantly less favorable attitudes toward pharmacotherapy, including disbelief about efficacy (p = .03), addiction concerns (p = .03), harmfulness of pharmacotherapy (p = .008), and need for treatment of any kind to quit smoking (p = .004). In a multiple logistic regression, racial group (Caucasian is referent: OR = 0.55, p = .003), addiction concerns (OR = 0.80, p < .01), and need for treatment of any kind to quit smoking (OR = 1.52, p < .001) were predictive of pharmacotherapy use. These findings replicate and build upon previous research demonstrating underutilization of pharmacotherapy and enduring misconceptions about pharmacotherapy, particularly among Black smokers. Regardless of racial group, misconceptions about pharmacotherapy are related to lower rates of use. Efforts to improve understanding about the efficacy and safety of these products are needed to boost utilization and impact cessation rates.Keywords
This publication has 38 references indexed in Scilit:
- Racial/ethnic differences in menthol cigarette smoking, population quit ratios and utilization of evidence‐based tobacco cessation treatmentsAddiction, 2010
- Stroke literacy in Central HarlemNeurology, 2009
- Race and Nicotine Replacement Treatment Outcomes Among Low-Income SmokersAmerican Journal of Preventive Medicine, 2008
- Understanding why smokers do not want to use nicotine dependence medications to stop smoking: Qualitative and quantitative studiesNicotine & Tobacco Research, 2008
- Racial/Ethnic Disparities in the Use of Nicotine Replacement Therapy and Quit Ratios in Lifetime Smokers Ages 25 to 44 YearsCancer Epidemiology, Biomarkers & Prevention, 2008
- A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populationsClinical Therapeutics, 2008
- Lung carcinoma in African AmericansNature Clinical Practice Oncology, 2007
- Perceived Discrimination and Adherence to Medical Care in a Racially Integrated CommunityJournal of General Internal Medicine, 2007
- Attitudes and knowledge about nicotine and nicotine replacement therapyNicotine & Tobacco Research, 2006
- Smoking cessation with and without assistanceAmerican Journal of Preventive Medicine, 2000